Variables | Cases n(%) | Controls n(%) | Total | |
---|---|---|---|---|
NRTI baseline | TDF base | 49(41.88) | 156(66.95) | 205(58.58) |
AZT based | 48(41.03) | 44(18.88) | 92(26.28) | |
D4Tbased | 20(17.09) | 33(14.16) | 53(15.14) | |
Total | 117(100) | 233(233) | 350(100) | |
Lost to follow up | Yes | 20(17.09) | 14(6.01) | 34(9.72) |
No | 97(82.91) | 219(93.99) | 316(90.28) | |
Total | 117(100) | 233(233) | 350(100) | |
Disclosure being HIV positive to family/others | Yes | 91(77.78) | 178(76.39) | 269(76.85) |
No | 26(22.22) | 55(23.61) | 81(23.14) | |
Total | 117(100) | 233(233) | 350(100) | |
Was there occurrence of drug side effect | Yes | 17(14.53) | 11(4.72) | 28(8) |
No | 100(85.47) | 222(95.28) | 322(92) | |
Total | 117(100) | 233(233) | 350(100) | |
Duration on first line ART | < 5 yrs | 17(14.53) | 1006(42.92) | 117(33.42) |
> = 5 yrs | 100(85.47) | 133(57.08) | 233(66.58) | |
Total | 117(100) | 233(233) | 350(100) | |
First line ART drug substitution | Yes | 43(36.75) | 48(20.60) | 91(26) |
No | 74(63.25) | 185(79.40) | 259(74) | |
Total | 117(100) | 233(233) | 350(100) | |
Time lag to start ART after diagnosed positive | The same month | 21(17..95) | 71(30.47) | 92(26.28) |
1 to 24 month | 78(66.67) | 146 (62.66) | 224(64) | |
Greater than 24 month | 18(15.38) | 16(6.87) | 34(9.72) | |
Total | 117(100) | 233(233) | 350(100) | |
Baseline CD4 count | < 100 | 46 (39.32) | 8 (3.43) | 54(15.42) |
> = 100 | 71 (60.68) | 225 (96.57) | 296(84.58) | |
Total | 117(100) | 233(233) | 350(100) | |
Recent CD4 count | < 100 | 20 (17.09) | 1(0.0.43) | 21(94) |
> = 100 | 97 (82.91) | 232(99.57) | 329(94) | |
Total | 117(100) | 233(233) | 350(100) | |
Baseline hemoglobin | < 11 | 22 (18.80) | 30(12.88) | 52(14.85) |
> = 11 | 95(81.20) | 203(87.12) | 298(85.14) | |
Recent hemoglobin | < 11 | 5(4.27) | 1(0.43) | 6(1.71) |
> = 11 | 112(95.73) | 232(99.57) | 344(98.29) | |
Total | 117(100) | 233(233) | 350(100) |